본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

President Message

print

The interest in personal healthcare continues to increase as quality of life improves and average lifespan increases. Moreover, the human beings are pursuing healthy and happy, quality life. In particular, the unprecedented spread of the COVID-19 pandemic has significantly shifted the paradigm and accelerated the growth of in-vitro diagnostic device industry that predicts, diagnoses, and prevents diseases early on.

Since its beginning in 1972 with blood typing test business, GC Medical Science has wide portfolio of products based on technology and know-how in the field of medical device and diagnostic reagents. In addition, our customer satisfaction is ever so increasing through our integrated management system from importation of diagnostic device to sales, installation, clinical application, and after-sales services.

The trend of medical device industry is already expanding from hardware-focused industry to digital industry. As such, GC Medical Science will continue to grow and develop as specialized company in diagnostics and medical devices even amongst the new ecosystem through our high level of technology accumulated over the past 50 years.

GC Medial Science will continuously strive to become transparent and stable global company by pursing sustainable future growth, considering our environment, and managing with social responsibility for healthy company, healthy people, and healthy world. .

Thank you to everyone in support of GC Medical Science.